Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopi
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2019 |
| Author/s |
author: Hidehisa Saeki Hidetsugu Tsubouchi |
| Publication date | November 11, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |